US Patent D1019381 Pharmaceutical package
Patent D1019381 was granted and assigned to Gilead Sciences on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent D1019381 Pharmaceutical package
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.